NextCure Competitors and Similar CompaniesClear all
NextCure's competitors and similar companies include Burning Rock Biotech and Ayala Pharmaceuticals.
 NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  Burning Rock Biotech Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology. |  Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. | |
Founding Date | Founding Date 2015 | Founding Date 2014 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Beltsville, US HQ | Locations Guang Zhou, CN HQ Beijing, CN Shanghai, CN Irvine, US | Locations Wilmington, US HQ Rehovot, IL Wilmington, US |
Employees | Employees N/A | Employees 674 | Employees 29 |
Valuation ($) | Valuation ($) 39.2 m | Valuation ($) 28.6 m | Valuation ($) 7.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥539.6m (FY, 2025) | Revenue (est.) $692k (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods ¥114.9m (FY, 2025) | Cost of goods $602k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit ¥424.7m (FY, 2025) | Gross profit $90k (FY, 2022) |
Net income | Net income ($55.8m) (FY, 2025) | Net income (¥55.3m) (FY, 2025) | Net income ($38m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 160m | Total funding raised $ 149.2m | Total funding raised $ 47m |
For sources of this data, please see the company profile
View Company Profiles
Burning Rock Biotech
HQ
Guang Zhou, CN
Employees
674
Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology.
View companyAyala Pharmaceuticals
HQ
Wilmington, US
Employees
29
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View company